Search Legislation

Commission Directive 2006/86/ECShow full title

Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells (Text with EEA relevance)

 Help about what version

What Version

More Resources

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Status:

EU Directives are being published on this site to aid cross referencing from UK legislation. After exit day no further amendments will be applied to this version.

  1. Introductory Text

  2. Article 1.Scope

  3. Article 2.Definitions

  4. Article 3.Requirements for the accreditation, designation, authorisation or licensing of tissue establishments

  5. Article 4.Requirements for the accreditation, designation, authorisation, licensing of tissue and cell preparation processes

  6. Article 5.Notification of serious adverse reactions

  7. Article 6.Notification of serious adverse events

  8. Article 7.Annual reports

  9. Article 8.Communication of information between competent authorities and to the Commission

  10. Article 9. Traceability

  11. Article 10. European coding system

  12. Article 10a. Format of the Single European Code

  13. Article 10b. Requirements related to the application of the Single European Code

  14. Article 10c. Accessibility and maintenance of the European coding system

  15. Article 10d. Transitional period

  16. Article 11.Transposition

  17. Article 12.Entry into force

  18. Article 13.Addressees

    1. ANNEX I

      Requirements for accreditation, designation, authorisation or licensing of tissue establishments as referred to in Article 3

      1. A. ORGANISATION AND MANAGEMENT

        1. 1. A responsible person must be appointed having qualifications and responsibilities...

        2. 2. A tissue establishment must have an organisational structure and operational...

        3. 3. Every tissue establishment must have access to a nominated medical...

        4. 4. There must be a documented quality management system applied to...

        5. 5. It must be ensured that the risks inherent in the...

        6. 6. Agreements between tissue establishments and third parties must comply with...

        7. 7. There must be a documented system in place, supervised by...

        8. 8. In the event of termination of activities the agreements concluded...

        9. 9. There must be a documented system in place that ensures...

      2. B. PERSONNEL

        1. 1. The personnel in tissue establishments must be available in sufficient...

        2. 2. All personnel should have clear, documented and up-to-date job descriptions....

        3. 3. Personnel must be provided with initial/basic training, updated training as...

      3. C. EQUIPMENT AND MATERIALS

        1. 1. All equipment and material must be designed and maintained to...

        2. 2. All critical equipment and technical devices must be identified and...

        3. 3. New and repaired equipment must be tested when installed and...

        4. 4. Maintenance, servicing, cleaning, disinfection and sanitation of all critical equipment...

        5. 5. Procedures for the operation of each piece of critical equipment,...

        6. 6. The procedures for the activities for which accreditation/designation/authorisation/licensing is sought,...

      4. D. FACILITIES/PREMISES

        1. 1. A tissue establishment must have suitable facilities to carry out...

        2. 2. When these activities include processing of tissues and cells while...

        3. 3. Unless otherwise specified in point 4, where tissues or cells...

        4. 4. A less stringent environment than specified in point 3 may...

        5. 5. In point 4(a), (b), (c) and (d), an environment must...

        6. 6. When the activities for which accreditation/designation/authorisation or licensing is sought...

        7. 7. Critical parameters (e.g. temperature, humidity, air quality) must be controlled,...

        8. 8. Storage facilities must be provided that clearly separate and distinguish...

        9. 9. The tissue establishment must have written policies and procedures for...

      5. E. DOCUMENTATION AND RECORDS

        1. 1. There must be a system in place that results in...

        2. 2. For every critical activity, the materials, equipment and personnel involved...

        3. 3. In the tissue establishments all changes to documents must be...

        4. 4. A document control procedure must be established to provide for...

        5. 5. Records must be shown to be reliable and a true...

        6. 6. Records must be legible and indelible and may be handwritten...

        7. 7. Without prejudice to Article 9(2), all records, including raw data,...

        8. 8. Records must meet the confidentiality requirements laid down in Article...

      6. F. QUALITY REVIEW

        1. 1. An audit system must be in place for the activities...

        2. 2. Deviations from the required standards of quality and safety must...

        3. 3. Corrective actions must be documented, initiated and completed in a...

        4. 4. The tissue establishment should have processes in place for review...

    2. ANNEX II

      Requirements for the authorisation of tissue and cell preparation processes at the tissue establishments as referred to in Article 4

      1. The competent authority shall authorise each tissue and cell preparation...

      2. A. RECEPTION AT THE TISSUE ESTABLISHMENT

      3. B. PROCESSING

      4. C. STORAGE AND RELEASE OF PRODUCTS

      5. D. DISTRIBUTION AND RECALL

      6. E. FINAL LABELLING FOR DISTRIBUTION

        1. 1. The primary tissue/cell container must provide:

        2. 2. The following information must be provided either on the label...

      7. F. EXTERNAL LABELLING OF THE SHIPPING CONTAINER

    3. ANNEX III

      NOTIFICATION OF SERIOUS ADVERSE REACTIONS

      1. PART A Rapid notification for suspected serious adverse reactions

      2. PART B Conclusions of Serious Adverse Reactions Investigation

    4. ANNEX IV

      NOTIFICATION OF SERIOUS ADVERSE EVENTS

      1. PART A Rapid notification for suspected serious adverse events

      2. PART B Conclusions of Serious Adverse Events investigation

    5. ANNEX V

      ANNUAL NOTIFICATION FORMAT

    6. ANNEX VI

      Minimum data to be kept in accordance with Article 9(2)

      1. A. BY TISSUE ESTABLISHMENTS

        1. (1) Donor identification

        2. (2) Donation identification that will include at least:

        3. (3) Product identification that will include at least:

        4. (4) Single European Code (if applicable)

        5. (5) Human application identification that will include at least:

      2. B. BY ORGANISATIONS RESPONSIBLE FOR HUMAN APPLICATION

        1. (1) Identification of the supplier tissue establishment

        2. (2) Identification of the clinician or end-user/facility

        3. (3) Type of tissues and cells

        4. (4) Product identification

        5. (5) Identification of the recipient

        6. (6) Date of application

        7. (7) Single European Code (if applicable)

    7. ANNEX VII

      THE STRUCTURE OF THE SINGLE EUROPEAN CODE

      1. DONATION IDENTIFICATION SEQUENCE PRODUCT IDENTIFICATION SEQUENCE EU TISSUE ESTABLISHMENT CODE...

    8. ANNEX VIII

      Data to be recorded in the EU Tissue Establishment Compendium

      1. A. Tissue establishment information

        1. 1. Name of the tissue establishment

        2. 2. National or international code of tissue establishment

        3. 3. Name of the organisation in which the tissue establishment is...

        4. 4. Address of the tissue establishment

        5. 5. Publishable contact details: functional e-mail address, phone and fax

      2. B. Details on the authorisation, accreditation, designation, or license of the...

        1. 1. Name of the authorising, accrediting, designating or licensing competent authority...

        2. 2. Name of the national competent authority or authorities responsible for...

        3. 3. Name of the authorisation, accreditation, designation or licence holder (if...

        4. 4. Tissues and cells for which the authorisation, accreditation, designation or...

        5. 5. Activities actually carried out for which the authorisation, accreditation, designation...

        6. 6. Status of the authorisation, accreditation, designation or license (authorised, suspended,...

        7. 7. Details of any conditions and exemptions added to the authorisation...

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex as well as any subsequent versions created after exit day as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-LEx and may not always coincide with when the changes came into force for the document.

For any versions created after exit day as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources